Literature DB >> 9886972

Genetic Disorders of Membrane Transport III. Congenital chloride diarrhea.

J Kere1, H Lohi, P Höglund.   

Abstract

Congenital chloride diarrhea (CLD) is a recessively inherited disorder of intestinal electrolyte absorption that involves, specifically, Cl-/HCO-3 exchange. CLD is caused by mutations in a chromosome 7 gene, first known as DRA (for downregulated in adenoma). The disease occurs in all parts of the world but is more common in some populations with genetic founder effects. More than 20 mutations in the gene are known to date. The CLD (or DRA) gene encodes a transmembrane protein belonging to the sulfate transporter family with three known members in humans, all associated with a distinct genetic disease. Members of the gene family can transport other anions as well that may turn out to be physiologically more important than sulfate transport. The gene family is well conserved in many prokaryotic and eukaryotic species and is expected to be much larger than presently known.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9886972     DOI: 10.1152/ajpgi.1999.276.1.G7

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  17 in total

Review 1.  Intestinal ion transport and the pathophysiology of diarrhea.

Authors:  Michael Field
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

Review 2.  Structure and function of the heat-stable enterotoxin receptor/guanylyl cyclase C.

Authors:  Arie B Vaandrager
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

3.  Transport properties of the human intestinal anion exchanger DRA (down-regulated in adenoma) in transfected HEK293 cells.

Authors:  Georg Lamprecht; Susannah Baisch; Elena Schoenleber; Michael Gregor
Journal:  Pflugers Arch       Date:  2004-10-05       Impact factor: 3.657

4.  Expression of prestin-homologous solute carrier (SLC26) in auditory organs of nonmammalian vertebrates and insects.

Authors:  Thomas Weber; Martin C Gopfert; Harald Winter; Ulrike Zimmermann; Hanni Kohler; Alexandra Meier; Oliver Hendrich; Karin Rohbock; Daniel Robert; Marlies Knipper
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-02       Impact factor: 11.205

5.  Congenital chloride-losing diarrhea causing mutations in the STAS domain result in misfolding and mistrafficking of SLC26A3.

Authors:  Michael R Dorwart; Nikolay Shcheynikov; Jennifer M R Baker; Julie D Forman-Kay; Shmuel Muallem; Philip J Thomas
Journal:  J Biol Chem       Date:  2008-01-23       Impact factor: 5.157

6.  Down-regulated in adenoma Cl/HCO3 exchanger couples with Na/H exchanger 3 for NaCl absorption in murine small intestine.

Authors:  Nancy M Walker; Janet E Simpson; Pei-Fen Yen; Ravinder K Gill; Elizabeth V Rigsby; Jennifer M Brazill; Pradeep K Dudeja; Clifford W Schweinfest; Lane L Clarke
Journal:  Gastroenterology       Date:  2008-08-07       Impact factor: 22.682

7.  Role of down-regulated in adenoma anion exchanger in HCO3- secretion across murine duodenum.

Authors:  Nancy M Walker; Janet E Simpson; Jennifer M Brazill; Ravinder K Gill; Pradeep K Dudeja; Clifford W Schweinfest; Lane L Clarke
Journal:  Gastroenterology       Date:  2008-11-08       Impact factor: 22.682

8.  Acute regulation of the SLC26A3 congenital chloride diarrhoea anion exchanger (DRA) expressed in Xenopus oocytes.

Authors:  Marina N Chernova; Lianwei Jiang; Boris E Shmukler; Clifford W Schweinfest; Paola Blanco; Steven D Freedman; Andrew K Stewart; Seth L Alper
Journal:  J Physiol       Date:  2003-03-21       Impact factor: 5.182

9.  Genetically encoded optical sensors for monitoring of intracellular chloride and chloride-selective channel activity.

Authors:  Piotr Bregestovski; Tatyana Waseem; Marat Mukhtarov
Journal:  Front Mol Neurosci       Date:  2009-12-04       Impact factor: 5.639

10.  Presence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancer.

Authors:  Vid Mlakar; Gasper Berginc; Metka Volavsek; Zdravko Stor; Miran Rems; Damjan Glavac
Journal:  BMC Cancer       Date:  2009-08-13       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.